Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Biotechnology

Healthcare
$39.15 +8.79%

+$2.32 today

Market cap
$1.83B
Beta
0.00
52W Low $23.00High $36.61

Volume 0.30M

Average 0.34M

COAG Deferred Revenue (Non-current)

Payments received for goods or services the company will deliver after more than one year.

Hemab Therapeutics Holdings, Inc. Common StockNASDAQ: COAG

Deferred Revenue (Non-current) · Q2 FY2026 · quarter ended Jun 2026

Deferred revenue (non-current) of $0 in Q2 FY2026

Q2 FY2026 deferred revenue (non-current) was $0.

Context

  • Deferred revenue (non-current) amounted to 0.0% of total assets at the end of Q2 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Deferred Revenue (Non-current) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Revenue (Non-current) history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Deferred Revenue (Non-current) vs competitors

How COAG compares with its peers on the latest reported figures

  • COAG's Jun 2026 deferred revenue (non-current) of $0 is the highest of the 5 companies compared; the peer median is $0.
  • Deferred revenue (non-current) amounts to 0.0% of total assets for COAG, versus a peer median of 0.0%.
COAG Competitors Peer median
Deferred Revenue (Non-current) for COAG and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
COAGHemab Therapeutics Holdings, Inc. Common StockJun 2026$0 ——0.0%
IRONDisc Medicine, Inc.Sep 2026$0 ——0.0%
QUREuniQure N.V.Mar 2026$0 ——0.0%
DMRADamora Therapeutics, Inc.Mar 2026$0 ——0.0%
RLYBRallybio CorporationMar 2026$0 ——0.0%
Peer median (excluding COAG) $0——0.0%

Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Intrinsic Alpha fair value

Locked

Current Price

$39.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.